19970305
 ImmuLogic responds to holders, replaces five board members   The Wall Street Journal,  Mar 6, 1997  ImmuLogic Pharmaceutical Corp, under pressure from disgruntled shareholders, replaced five of eight members of its board, including founder and chairman Malcolm Gefter. Shares of the struggling biotechnology company surged 11% on the news, closing at $6.375, up 75 cents, in Nasdaq Stock Market trading.   
